![](/accounts/eme/images/logo.png)
A. Bray Review Course
-
Register
- Member - $300
This Review Course is specifically designed for individuals wishing to take the ABOM Certification Exam. This package consists of 14 presentations covering the key topics included in the ABOM Certification Exam. Upon successful completion of the Review Course, participants will earn eight (8) AMA Category 1 Credits. This course also provides credits for the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC). All presentations are ABOM-designated GROUP ONE credits.
Price: $300 USD
This activity has been approved for AMA PRA Category 1 Credits™
Advanced Search This List
-
Contains 2 Component(s)
Presented by Gitanjali Srivastava, MD, FACP, FAAP, FTOS
Learning Objectives:
- Understanding Genetic Contributions to Obesity
- By the end of this talk, participants will be able to describe the role of genetic factors in obesity susceptibility.
- Exploring Epigenetic Mechanisms in Obesity Development
- After this session, participants will be familiar with epigenetic modifications related to obesity.
- Recognizing Environmental Drivers of Obesity
- By the end of this talk, participants will be able to identify key environmental factors contributing to obesity.
-
Contains 6 Component(s)
Part 1: Presented by Steven Heymsfield, MD. Part 2: Presented by Eric Ravussin, PhD. Part 3: Presented by Christopher D. Morrison, PhD
Part 1: Physiologic Regulation of Body Weight and Body Composition
Presented by Steven Heymsfield, MD
Learning Objectives:
- Describe the key features and regulatory pathway for dietary supplements for weight loss.
- Identify the ingredients and their effectiveness that comprise dietary supplements.
Part 2: Energy Homeostasis: Role of Energy Expenditure in Weight Regulation
Presented by Eric Ravussin, PhD
Learning Objectives:
- You will learn that energy balance is not simply derived from energy intake and energy expenditure but needs to consider fat, carbohydrate and protein balances as different entities.
- You will also be presented with data showing that a low energy expenditure, a low fat oxidation and a low sympathetic activity are all risk factors for weight gain.
- Finally, the concept of metabolic adaptation will be discussed.
Part 3: Obesity and the Brain: Why and How Surgery and Pharmacotherapy work
Presented by Christopher D. Morrison, PhD
Learning Objectives:
- Generally understand how interoceptive mechanisms coordinate food intake in response to changes in nutritional state.
- Understand the mechanisms through which nutritional information is communicated to the brain.
- Understand the role of the brain in the weight loss effects of GLP1-based pharmaceuticals and bariatric surgery
-
Contains 2 Component(s)
Presented by Vance Albaugh, MD, PhD
Presented by Vance Albaugh, MD, PhD
Learning Objectives:
• Have a broad understanding of the initial assessment of the patient with obesity, specifically the weight loss/weight gain history.
• Understand the rationale for the typical screening tests and workup to complement the weight loss/weight gain history.
• Understand the general rationale of “obesity staging” and how it guides treatment decisions.
-
Contains 2 Component(s)
Presented by Catherine M. Champagne, PhD, RDN, LDN
Presented by Catherine M. Champagne, PhD, RDN, LDN
Learning Objectives:
- Attendees will be able to describe what the clinical nutrition assessment prior to bariatric surgery entails, and why this is best completed by a Registered Dietitian.
- Attendees will be able to determine what diets prior to bariatric surgery and post bariatric surgery are most appropriate for the patient.
-
Contains 2 Component(s)
Presented by Jamy Ard, MD
Learning Objectives:
- Understand the role of dietary patterns and meal replacements in the treatment of obesity.
-
Contains 2 Component(s)
Presented by Neil M. Johannsen, PhD
Learning Objectives:
- Describe key component of a behavioral weight loss intervention.
- Identify good candidates for an intensive behavioral intervention in your practice.
-
Contains 2 Component(s)
Presented by Philip J. Brantley, PhD, FTOS
Learning Objectives:
- Describe key component of a behavioral weight loss intervention.
-
Contains 2 Component(s)
Presented by Donna Ryan, MD
Learning Objectives:
- At the end of the presentation attendees will be able to discuss the following breakthroughs:
- Tirzepatide treatment for adult obesity shows >90% can achieve >10% weight loss;
- Semaglutide gets FDA indication for obesity management in children age 12-18;
- Semaglutide for obesity achieves indication for secondary prevention of cv events;
- Semaglutide shows promise in HFpEF and chronic kidney disease;
- Obesity drug development uses GLP-1 backbone with 4 new compounds in phase 3; and
- Post-marketing surveillance posts reassuring
-
Contains 4 Component(s)
Part 1: Presented by Vance Albaugh, MD, PhD. Part 2: Presented by Philip Schauer, MD, FACS, FASMBS
Part 1: Guidelines, overview of procedures, benefits, pre-surgery assessment
Presented by Vance Albaugh, MD, PhD
Learning Objectives:
- Be familiar with the updated guidelines/indications for metabolic/bariatric surgery.
- Identify the most common metabolic/bariatric operations that are currently utilized in the United States.
- Understand contraindications to metabolic/bariatric surgery.
- Understand the rationale for commonly used testing in the preoperative surgical patient.
Part 2: Post-op complications, long term health maintenance, weight regain
Presented by Philip Schauer, MD, FACS, FASMBS
Learning Objectives:
- Summarize Long-term Benefits of Metabolic Surgery
- Review Post-Operative Management
-
Contains 2 Component(s)
Presented by Gitanjali Srivastava, MD, FACP, FAAP, FTOS
Learning Objectives:
- Understanding Genetic Obesity Mechanisms:
- By the end of this talk, participants will be able to explain the underlying genetic factors contributing to obesity.
- Recognizing Clinical Features in Genetic Obesity: Unmasking Hyperphagia
- By the end of this talk, participants will be able to recognize key clinical features associated with genetic obesity, including hyperphagia, and understand the importance of identifying pathological hunger and cravings.
- Recognizing Syndromic Obesity Patterns:
- By the end of this talk, participants will be able to recognize common syndromes associated with obesity.
-
Contains 2 Component(s)
Presented by Gitanjali Srivastava, MD, FACP, FAAP, FTOS
Learning Objectives:
- Understanding Genetic Contributions to Obesity
- By the end of this talk, participants will be able to describe the role of genetic factors in obesity susceptibility.
- Exploring Epigenetic Mechanisms in Obesity Development
- After this session, participants will be familiar with epigenetic modifications related to obesity.
- Recognizing Environmental Drivers of Obesity
- By the end of this talk, participants will be able to identify key environmental factors contributing to obesity.
- Understanding Genetic Contributions to Obesity
-
Contains 6 Component(s)
Part 1: Presented by Steven Heymsfield, MD. Part 2: Presented by Eric Ravussin, PhD. Part 3: Presented by Christopher D. Morrison, PhD
Part 1: Physiologic Regulation of Body Weight and Body Composition
Presented by Steven Heymsfield, MD
Learning Objectives:
- Describe the key features and regulatory pathway for dietary supplements for weight loss.
- Identify the ingredients and their effectiveness that comprise dietary supplements.Part 2: Energy Homeostasis: Role of Energy Expenditure in Weight Regulation
Presented by Eric Ravussin, PhD
Learning Objectives:
- You will learn that energy balance is not simply derived from energy intake and energy expenditure but needs to consider fat, carbohydrate and protein balances as different entities.
- You will also be presented with data showing that a low energy expenditure, a low fat oxidation and a low sympathetic activity are all risk factors for weight gain.
- Finally, the concept of metabolic adaptation will be discussed.Part 3: Obesity and the Brain: Why and How Surgery and Pharmacotherapy work
Presented by Christopher D. Morrison, PhD
Learning Objectives:
- Generally understand how interoceptive mechanisms coordinate food intake in response to changes in nutritional state.
- Understand the mechanisms through which nutritional information is communicated to the brain.
- Understand the role of the brain in the weight loss effects of GLP1-based pharmaceuticals and bariatric surgery -
Contains 2 Component(s)
Presented by Vance Albaugh, MD, PhD
Presented by Vance Albaugh, MD, PhD
Learning Objectives:
• Have a broad understanding of the initial assessment of the patient with obesity, specifically the weight loss/weight gain history.
• Understand the rationale for the typical screening tests and workup to complement the weight loss/weight gain history.
• Understand the general rationale of “obesity staging” and how it guides treatment decisions. -
Contains 2 Component(s)
Presented by Catherine M. Champagne, PhD, RDN, LDN
Presented by Catherine M. Champagne, PhD, RDN, LDN
Learning Objectives:
- Attendees will be able to describe what the clinical nutrition assessment prior to bariatric surgery entails, and why this is best completed by a Registered Dietitian.
- Attendees will be able to determine what diets prior to bariatric surgery and post bariatric surgery are most appropriate for the patient. -
Contains 2 Component(s)
Presented by Jamy Ard, MD
Learning Objectives:
- Understand the role of dietary patterns and meal replacements in the treatment of obesity.
-
Contains 2 Component(s)
Presented by Neil M. Johannsen, PhD
Learning Objectives:
- Describe key component of a behavioral weight loss intervention.
- Identify good candidates for an intensive behavioral intervention in your practice.
-
Contains 2 Component(s)
Presented by Philip J. Brantley, PhD, FTOS
Learning Objectives:
- Describe key component of a behavioral weight loss intervention.
-
Contains 2 Component(s)
Presented by Donna Ryan, MD
Learning Objectives:
- At the end of the presentation attendees will be able to discuss the following breakthroughs:
- Tirzepatide treatment for adult obesity shows >90% can achieve >10% weight loss;
- Semaglutide gets FDA indication for obesity management in children age 12-18;
- Semaglutide for obesity achieves indication for secondary prevention of cv events;
- Semaglutide shows promise in HFpEF and chronic kidney disease;
- Obesity drug development uses GLP-1 backbone with 4 new compounds in phase 3; and
- Post-marketing surveillance posts reassuring
- At the end of the presentation attendees will be able to discuss the following breakthroughs:
-
Contains 4 Component(s)
Part 1: Presented by Vance Albaugh, MD, PhD. Part 2: Presented by Philip Schauer, MD, FACS, FASMBS
Part 1: Guidelines, overview of procedures, benefits, pre-surgery assessment
Presented by Vance Albaugh, MD, PhD
Learning Objectives:
- Be familiar with the updated guidelines/indications for metabolic/bariatric surgery.
- Identify the most common metabolic/bariatric operations that are currently utilized in the United States.
- Understand contraindications to metabolic/bariatric surgery.
- Understand the rationale for commonly used testing in the preoperative surgical patient.Part 2: Post-op complications, long term health maintenance, weight regain
Presented by Philip Schauer, MD, FACS, FASMBS
Learning Objectives:
- Summarize Long-term Benefits of Metabolic Surgery
- Review Post-Operative Management -
Contains 2 Component(s)
Presented by Gitanjali Srivastava, MD, FACP, FAAP, FTOS
Learning Objectives:
- Understanding Genetic Obesity Mechanisms:
- By the end of this talk, participants will be able to explain the underlying genetic factors contributing to obesity.
- Recognizing Clinical Features in Genetic Obesity: Unmasking Hyperphagia
- By the end of this talk, participants will be able to recognize key clinical features associated with genetic obesity, including hyperphagia, and understand the importance of identifying pathological hunger and cravings.
- Recognizing Syndromic Obesity Patterns:
- By the end of this talk, participants will be able to recognize common syndromes associated with obesity.
- Understanding Genetic Obesity Mechanisms: